Global Stem Cell Partnering 2010-2017: Deal trends, players, financials and forecasts

Publisher Name :
Date: 01-Nov-2017
No. of pages: 370
Inquire Before Buying

"Delivery of this report will take 1-3 days after purchase."

The Global Stem Cell Partnering 2010-2017: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the stem cell partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in stem cell partnering

Deal terms analysis

Partnering agreement structure

Partnering contract documents

Top deals by value

Most active dealmakers

Average deal terms for stem cells

The report provides a detailed understanding and analysis of how and why companies enter Stem Cell partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.

This report provides details of the latest Stem Cell agreements announced in the life sciences since 2010.

The report takes the reader through a comprehensive review Stem Cell deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Stem Cell partnering deals.

The report presents financial deal term values for Stem Cell deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Stem Cell partnering field; both the leading deal values and most active Stem Cell dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 500 online deal records of actual Stem Cell deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of Stem Cell dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Stem Cell dealmaking since 2010, including details of headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading Stem Cell deals since 2010. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in Stem Cell dealmaking with a brief summary followed by a comprehensive listing of Stem Cell deals announded by that company, as well as contract documents, where available.

Chapter 5 provides a comprehensive and detailed review of Stem Cell partnering deals signed and announced since Jan 2010, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of Stem Cell partnering deals signed and announced since Jan 2010. The chapter is organized by specific Stem Cell technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

A comprehensive series of appendices is provided organized by Stem Cell partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Stem Cell partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Stem Cell technologies and products.

Key benefits

Global Stem Cell Partnering 2010-2017: Deal trends, players, financials and forecasts provides the reader with the following key benefits:

In-depth understanding of Stem Cell deal trends since 2010

Access to headline, upfront, milestone and royalty data

Analysis of the structure of Stem Cell agreements with numerous real life case studies

Detailed access to actual Stem Cell contracts entered into by leading biopharma companies

Identify most active Stem Cell dealmakers since 2010

Insight into terms included in a Stem Cell partnering agreement, with real world examples

Understand the key deal terms companies have agreed in previous deals

Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Global Stem Cell Partnering 2010-2017: Deal trends, players, financials and forecasts is intended to provide the reader with an in-depth understanding and access to Stem Cell trends and structure of deals entered into by leading companies worldwide.

Stem Cell Partnering Terms and Agreements includes:

Trends in Stem Cell dealmaking in the biopharma industry since 2010

Analysis of Stem Cell deal structure

Access to headline, upfront, milestone and royalty data

Case studies of real-life Stem Cell deals

Access to Stem Cell contract documents

Leading Stem Cell deals by value since 2010

Most active Stem Cell dealmakers since 2010

In Global Stem Cell Partnering 2010-2017: Deal trends, players, financials and forecasts, the available deals are listed by:

Company A-Z

Headline value

Stage of development at signing

Deal component type

Specific therapy target

Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Stem Cell Partnering 2010-2017: Deal trends, players, financials and forecasts report provides comprehensive access to available deals and contract documents for over 500 Stem Cell deals.

Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How aresalesand payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Global Stem Cell Partnering 2010-2017: Deal trends, players, financials and forecasts

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Stem Cell dealmaking
2.1. Introduction
2.2. Stem Cell partnering over the years
2.3. Most active Stem Cell dealmakers
2.4. Stem Cell partnering by deal type
2.5. Stem Cell partnering by therapy area
2.6. Deal terms for Stem Cell partnering
2.6.1 Stem Cell partnering headline values
2.6.2 Stem Cell deal upfront payments7
2.6.3 Stem Cell deal milestone payments
2.6.4 Stem Cell royalty rates

Chapter 3 - Leading Stem Cell deals
3.1. Introduction
3.2. Top Stem Cell deals by value

Chapter 4 - Most active Stem Cell dealmakers
4.1. Introduction
4.2. Most active Stem Cell dealmakers
4.3. Most active Stem Cell partnering company profiles

Chapter 5 - Stem Cell contracts dealmaking directory
5.1. Introduction
5.2. Stem Cell contracts dealmaking directory

Chapter 6 - Stem Cell dealmaking by technology type

Chapter 7 - Partnering resource center
7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices

Appendix 1 - Stem Cell deals by company A-Z

Appendix 2 - Stem Cell deals by stage of development

Discovery
Preclinical
Phase I
Phase II
Phase III
Regulatory
Marketed
Formulation

Appendix 3 - Stem Cell deals by deal type

Asset purchase
Assignment
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Litigation
Manufacturing
Marketing
Material transfer
Option
Promotion
Research
Settlement
Spin out
Sub-license
Supply
Technology transfer
Termination
Warranty

Appendix 4 - Stem Cell deals by therapy area

Appendix 5 -Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering

List of Figures

Figure 1: Stem Cell partnering since 2010
Figure 2: Active Stem Cell dealmaking activity since 2010
Figure 3: Stem Cell partnering by deal type since 2010
Figure 4: Stem Cell partnering by disease type since 2010
Figure 5: Stem Cell deals with a headline value
Figure 6: Stem Cell deals with an upfront value
Figure 7: Stem Cell deals with a milestone value
Figure 8: Stem Cell deals with a royalty rate value
Figure 9: Top Stem Cell deals by value since 2010
Figure 10: Most active Stem Cell dealmakers since 2010
Figure 11: Online partnering resources
Figure 12: Forthcoming partnering events
  • China Stem Cell Therapy Market Research Report 2017
    Published: 04-Dec-2017        Price: US 3400 Onwards        Pages: 113
    The global Stem Cell Therapy market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%. This report studies the Stem Cell Therapy development status and future trend in China, focuses on top players in China, also splits Stem Cell ......
  • Global Autologous Cell Therapy Market Size, Status and Forecast 2022
    Published: 24-Nov-2017        Price: US 3300 Onwards        Pages: 91
    This report studies the global Autologous Cell Therapy market, analyzes and researches the Autologous Cell Therapy development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Vericel Corporation - BioTime - Pharmicell - BrainStorm Cell Therapeutics - Opexa Therapeutics Market segment by Regions/Countries, this report covers - United States......
  • Global Stem Cell Therapy Market Professional Survey Report 2017
    Published: 23-Nov-2017        Price: US 3500 Onwards        Pages: 119
    This report studies Stem Cell Therapy in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Cellular Dynamics International - Osiris Therapeutics - Vcanbio - ......
  • North America Animal Stem Cell Therapy Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 20-Nov-2017        Price: US 4480 Onwards        Pages: 119
    Animal stem cell therapy is a usage of animal's stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site ......
  • Global and Regional Animal Stem Cell Therapy Market Research Report 2017
    Published: 19-Nov-2017        Price: US 3500 Onwards        Pages: 147
    Summary Animal stem cell therapy is a usage of animal's stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into th......
  • United States Stem Cell Therapy Market Report 2017
    Published: 02-Nov-2017        Price: US 3800 Onwards        Pages: 109
    In this report, the United States Stem Cell Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate o......
  • Global Stem Cell Therapy Sales Market Report 2017
    Published: 30-Oct-2017        Price: US 4000 Onwards        Pages: 116
    In this report, the global Stem Cell Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Stem Cell Therapy for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan......
  • Global Stem Cell Therapy Market Research Report 2017
    Published: 18-Oct-2017        Price: US 2900 Onwards        Pages: 110
    In this report, the global Stem Cell Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Stem Cell Therapy in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China -......
  • Stem Cell Therapy for Diabetes and Related Conditions - A Pipeline Analysis Report
    Published: 13-Oct-2017        Price: US 3500 Onwards        Pages: 93
    The stem cell therapy for diabetes and related conditions pipeline analysis report includes ongoing clinical and non-clinical trends in the global stem cell therapy for diabetes and related conditions treatment. Most of the pipeline therapeutics are in early stage of development, a long-lasting and less frequent dose can impact overall diabetes market. In 2015, the American Diabetes Association (ADA) estimated that the annual total cost of diabetic patients is $223.5 billion in the US......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs